Ois Podcast
New CEO Mattessich Brings in New Skills, Leadership to Help Ocular Therapeutix Reach Potential
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:38:37
- Mas informaciones
Informações:
Sinopsis
New CEO Antony Mattessich says Ocular Therapeutix has learned its mistakes after receiving two CRLs from the FDA. With new leadership and a clear vision, the company is ready to push forward as a full-fledged biopharmaceutical company.
